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Mycobacterium abscessus is a multidrug-resistant spe-cies of nontuberculous mycobacteria (NTM) that has recently emerged as a major threat to individuals with CF, 
with increasing rates of infection seen in CF cohorts around the 
world1. This rapidly growing NTM is divided into three subspecies: 
M. abscessus subspecies abscessus (M. a. abscessus), M. a. massiliense 
and M. a. bolletii2. Infections with M. abscessus lead to accelerated 
inflammatory lung damage3, are often difficult or impossible to 
treat despite prolonged courses of combination antibiotics4–6 and 
may prevent safe lung transplantation1,7.
Although M. abscessus was originally thought to only be indepen-
dently acquired from the environment, we8 and others9 have shown 
that individuals with CF can become infected through hospital-based 
person-to-person transmission (probably through the generation of 
long-lived infectious aerosols or via fomite spread2). Indeed, large 
scale whole genome sequencing of M. abscessus isolates from CF 
centres around the world has revealed that most individuals with 
CF are infected with one of three highly prevalent globally dispersed 
clones, referred to as DCCs 1–3 (ref. 2). Assigning the DCC classi-
fication onto whole genome sequences from other studies indicates 
that the DCCs can also infect non-CF individuals10,11. DCC isolates 
are associated with worse clinical outcomes, have greater antibiotic 
resistance and are more virulent in in vitro and in vivo infection 
models2, suggesting that multiple rounds of within-host evolution 
have promoted increased pathogenic potential.
The high levels of genetic relatedness within the DCCs suggest 
that they have emerged recently and have rapidly spread within and 
between countries, as well as across continents2,10,12,13. There are 
many examples of isolates from individuals in different CF centres 
or in different countries whose sequences differ by fewer mutations 
than have been seen in a single individual during chronic infec-
tion2,14, suggesting individuals are linked by recent and widespread 
transmission networks. However, despite multiple studies combin-
ing whole genome sequencing with epidemiological data2,8,9,13–18, 
the relative importance of different routes of acquisition remains 
unclear. In addition, the mechanism of transcontinental spread of 
DCCs6 (given the lack of movement of CF individuals) is unknown. 
Several studies have found near-identical isolates in CF individuals 
with no obvious epidemiological links15–18, suggesting that transmis-
sion chains include additional unknown links, potentially implicat-
ing environmental or human intermediates.
To understand how the M. abscessus DCCs emerged and the 
routes through which they have spread globally, we have applied 
evolutionary phylogenetic analyses to whole genome sequences 
of clinical isolates from 1,178 individuals on five continents. We 
show that the DCCs expanded synchronously around the time of 
increases in CF life expectancy, spread globally (particularly from 
Europe to North America) and contain a mutagenic signature of 
exposure to smoking-related mutagens during their expansion, 
implicating smokers and more generally non-CF individuals, as an 
important second human niche for M. abscessus.
Results
Synchronous clonal expansions coincident with the emergence 
of the CF lung niche. We first reconstructed the phylogenetic rela-
tionships between 2,045 M. abscessus whole genome sequences 
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from 1,178 individuals to identify recently emerged clones whose 
ancestry could be dated. We identified seven clonal clusters, includ-
ing the three previously identified DCCs2, that contained highly 
related isolates from at least 20 individuals (Fig. 1a and Extended 
Data Fig. 1) and were found on multiple continents (Fig. 1b and 
Supplementary Table 1). We classified these clones as DCC1–7.
Bayesian temporal reconstruction19 indicated that each of the 
DCCs emerged relatively recently, with their most recent common 
ancestors dating between 1902 and 1999 (Fig. 1c). The dated phylo-
genetic tree of each DCC is characterized by a section with multiple 
concurrent short branches, indicating a historical period of rapid 
expansion from a small number of lineages into multiple indepen-
dent transmission chains that have persisted to the present day 
(Fig. 1c). In support of this conclusion, we found strong statistical 
evidence (posterior probability of one for each DCC, Methods) that 
each DCC had undergone at least one historical population expan-
sion, the first of which occurred for six of the seven DCCs in the 
1960s and for DCC4 much later (Fig. 1d).
We proposed that the expansion in DCCs could have been driven 
by changes within the CF population since M. abscessus has become 
a main cause of lung infection in individuals with CF1, can transmit 
onwards from CF individuals2,8 and is more prevalent in this cohort 
than in other patient groups20. We found that the DCC expansion 
occurred shortly after life expectancy of CF individuals began to 
increase from infancy to over 10 years of age in the 1950s and 1960s 
(Extended Data Fig. 2)21,22. This period also saw the establishment 
of CF treatment centres and the widespread use of antipseudomonal 
and antistaphylococcal antibiotics21 (to which M. abscessus is intrin-
sically resistant) (Extended Data Fig. 2), suggesting that the syn-
chronous expansion of DCCs in the 1960s may have been driven 
both by increases in the number and density of susceptible indi-
viduals (promoting person-to-person transmission2,8) and also the 
creation of a more permissive lung niche for M. abscessus, through 
suppression of other lung pathogens1,23. The more recent expansion 
of DCC4 in the mid-2000s (Fig. 1d) suggests that suitable condi-
tions for the emergence of new clones have persisted within present 
day patient cohorts.
Rare intercontinental transmission events drive global transmis-
sion networks. We next investigated the global transmission net-
work of M. abscessus by reconstructing the broad-scale geographical 
distribution of the three most prevalent clones, DCCs 1–3. In each 
case, isolates from different continents are interspersed within the 
phylogenetic tree (Fig. 2a), demonstrating historical intercontinen-
tal transmission events that are relatively uncommon, with approxi-
mately one out of every 50 lineages moving between continents 
each year (Fig. 2b). Furthermore, we found a significant correlation 
between the age of a clade and the number of continents it has been 
detected in, with most newly emerged clades only present in one 
continent (Extended Data Fig. 3). However, despite these low over-
all rates of intercontinental transmission, we found strong evidence 
for migration of M. abscessus between specific pairs of continents 
and, in particular, of migration of all three main DCCs from Europe 
to North America (Fig. 2c), potentially driven by the high density of 
CF individuals in Europe24,25.
Mutational spectrum analysis implicates smokers in DCC trans-
mission networks. While our results indicate a major role for 
individuals with CF in the expansion of DCCs, it is clear from our 
temporal reconstruction that several of the DCCs emerged within 
the human population before CF survival increased beyond early 
childhood (Fig. 1c), suggesting an alternative pre-existing niche. 
Similarly, the transcontinental spread of DCCs is difficult to explain 
without an alternative human vector for transmission, given the his-
torically limited travel of CF individuals.
We therefore proposed that individuals who smoke, given their 
recognized predisposition to mycobacterial infection26–29, might 
have provided the early niche for DCC emergence and facilitated 
their global dissemination. To test this hypothesis, we performed 
a mutational spectrum analysis of the M. abscessus genomes. The 
mutational spectrum is the pattern of different types of DNA muta-
tion arising as a consequence of the action of various mutagenic 
processes and DNA repair mechanisms over time30,31. Since bacteria 
are likely to be exposed to different mutagens during pulmonary 
infection than when in the environment, we reasoned that we could 
use mutational spectrum analysis to define the historical exposure 
of DCCs to these different niches.
We first calculated the spectrum of mutations in M. abscessus 
attributable to the environment, by analysing mutations occurring 
along the internal phylogenetic branches of the non-DCC clades, 
which constitute long periods of predominantly or exclusively envi-
ronmental replication (Fig. 3a,b). We were then able to define the 
specific mutational profile arising only during chronic infection of 
CF individuals (by examining within-patient longitudinal samples), 
and the profile generated during the expansion and dissemination 
of DCCs (by looking at the internal branches of the DCC phylog-
enies), which were both notably different from the spectrum attrib-
utable to the environment and from each other (Fig. 3c).
Decomposition analysis32 (Fig. 3d) suggests that the environmen-
tal mutational spectrum consists of contributions from spontaneous 
mutation events (arising from cytosine deamination and inefficient 
homologous recombination repair) and mutations caused by alkyl-
ating agents, some of which have previously been reported to be 
present in soil33,34. In contrast, the within-CF patient spectrum has 
contributions from mutations associated with exposure to reac-
tive oxygen species (ROS)30, thought to be generated at high levels 
within the CF lung35.
We found that the DCC-specific spectrum, in addition to having 
some contribution from ROS-related mutagenesis, was dominated 
by a general (context-independent) elevation in C-to-A/G-to-T 
mutations, a pattern seen in lung cancers from smokers36 and in 
human cells exposed to tobacco smoke in vitro30 (Fig. 3d). We can 
therefore infer that the DCC expansion and transmission networks 
involve smokers as well as individuals with CF.
Individuals with CF and without CF (non-CF) are involved in 
DCC transmission networks. Given the mutational evidence of 
involvement of smokers in the initial emergence and continued 
transmission of the DCCs, we sought to quantify whether current 
transmission networks included both those with and without CF, 
or whether they form discrete transmission chains. We found that 
Fig. 1 | emergence of M. abscessus DCCs. a, The phylogenetic placement of the DCCs in the M. abscessus species phylogenetic tree. Several non-DCC 
clades have been collapsed for clarity; the full tree is presented in Extended Data Fig. 1. b, The proportion of individuals from each location infected with 
each DCC. All samples from Brazil are from a surgical outbreak caused by a single lineage30. c, Temporal maximum clade credibility phylogenetic tree of 
each DCC. DCC most recent common ancestor dates are shown as median with 95% HPD in parentheses. Shaded areas show the first period of rapid 
divergence in each DCC. d, Expansion date distributions for each DCC as calculated from the complete posterior distribution of trees (number of samples 
from the posterior distribution: DCC1 = 2,255, DCC2 = 2,255, DCC3 = 2,255, DCC4 = 2,699, DCC5 = 2,702, DCC6 = 2,613, DCC7 = 2,703). Boxplot centre 
lines show median value; upper and lower bounds show the 25th and 75th quantile, respectively; upper and lower whiskers show the largest and smallest 
values within 1.5 times the interquartile range above the 75th percentile and below the 25th percentile, respectively; and points show samples outside the 
whisker range.
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isolates from the lungs of individuals with and without CF could 
both be found in all seven DCCs (Fig. 4a, Extended Data Fig. 4a and 
Supplementary Table 2) and in non-DCCs (Extended Data Fig. 4b), 
showing that all of the emergent clones are capable of infecting 
members of either group. We then linked individuals on the basis 
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polymorphisms (SNPs), using a range of linkage cut-offs that capture 
possible person-to-person transmission2. This demonstrated many 
close acquisition linkages between individuals within both DCC 
and non-DCC clades (Fig. 4b and Extended Data Fig. 5), showing 
that M. abscessus transmission is not limited to just the DCCs and 
raising the possibility of the emergence or discovery of more circu-
lating clones in the future. We showed that local linkages dominate 
at smaller genetic distances, with national and then international 
linkages becoming more frequent at higher SNP distances (Fig. 4c 
and Extended Data Fig. 5); the expected signature of geographical 
spread of transmissible clones. We were also able to show that, at all 
genetic distances, linkages could be identified between individuals 
with CF, between individuals with and without CF and directly 
between individuals without CF (Fig. 4c and Extended Data Fig. 5) 
(although the relative proportions of these will be confounded by 
the different levels of sampling in the two groups). To confirm this 
apparent linkage between individuals with and without CF, we 
reconstructed transmission networks on the basis of SNP cut-offs 
of 10 and 38 SNPs (representing likely and possible transmission 
based on within-host diversity2, Fig. 4d). At both cut-off levels, 
transmission networks exist that include both individuals with and 
without CF, with each group exhibiting strong connectivity within 
the network (Extended Data Fig. 6). We further investigated the 
largest network (which consists of isolates from DCC1 from both 
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Fig. 2 | global migration network of the DCCs. a, Phylogeographic trees for DCCs 1–3. Each branch is coloured by continent. b, Intercontinental migration 
rates for each DCC for the complete dataset and five random subsamples (Methods, number of samples from the posterior distribution: DCC1 complete 
dataset of 3,157, all DCC1 subsampled datasets, DCC2 subsampled datasets 1, 3 and 5, all DCC3 subsampled datasets of 2,703 each; DCC2 complete 
dataset, DCC2 subsampled datasets 2 and 4, DCC3 complete dataset of 2,256 each). Boxplot centre lines show median value; upper and lower bounds 
show the 25th and 75th quantile, respectively; upper and lower whiskers show the largest and smallest values within 1.5 times the interquartile range above 
the 75th percentile and below the 25th percentile, respectively; and points show samples outside the whisker range. The median and 95% HPD of the 
complete DCC datasets are shown above the bars of the corresponding DCC. An intercontinental migration rate of 0.02 migrations per lineage per year 
corresponds to one in 50 lineages moving continent in a year. c, Intercontinental migration pathways for each DCC. Arrows show the direction of supported 
migration from source continent to recipient continent. Arrows are coloured by originating continent.
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individuals with and without CF, Fig. 4e) and found that this net-
work had a global reach, with multiple international and national 
connections evident.
Discussion
Halting the growing rate of infections with M. abscessus will require 
a comprehensive understanding of how individuals acquire these 
infections and how the bacteria spread at local and global scales. 
We have applied evolutionary analyses of whole genome sequences 
to reconstruct the population history, spatiotemporal spread and 
mutational history of M. abscessus. Our analysis demonstrates a key 
role for person-to-person transmission in M. abscessus epidemiol-
ogy. The synchronized expansion of six of the seven DCCs (appar-
ent despite their different sample numbers, sample density and tree 
depths) was tightly associated with a period of multiple changes 
in the CF population (Fig. 1d and Extended Data Fig. 2), indicat-
ing that the expansion was probably driven by the establishment of 
person-to-person transmission chains on the emergence of the CF 
lung niche. It is possible that these expansions may have addition-
ally been promoted by increasing tobacco smoking rates in devel-
oped countries seen from the early 1900s to a peak around 1980 
(Extended Data Fig. 2).
The rapid diversification in the DCC trees in the 1960s (Fig. 1c) 
can only be explained by multiple independent transmission chains 
that were established at this time, have persisted to the present day, 
and which involve both CF and non-CF individuals (Fig. 4). The age 
of these clones, the large number of individuals linked at very small 
SNP distances (Fig. 4), the high frequency of long range national 
and international linkages, and the correlation between genetic 
and geographical distance (Fig. 4c) are all patterns expected of a 
human lung pathogen and effectively rule out the hypothesis that a 
broadly spread genetically homogeneous environmental clone can 
explain the infection of CF individuals with related isolates18. While 
the main niche for the DCCs appears to be within human lungs, 
transmission is likely to be indirect and involve environmental and 
fomite intermediates2,8, which may lead to extrapulmonary DCC 
infections.
The smoking-related mutational signature that we identified 
within the DCCs (Fig. 3c,d) occurred along the internal phyloge-
netic branches within these clones, indicating that smokers have 
contributed to the expansion and continued transmission chains 
of M. abscessus DCCs. Smokers exhibit increased susceptibility 
to many infections, including NTMs26,27,29,37,38 and Mycobacterium 
tuberculosis28, due to structural lung changes and impaired immune 
responses39–41. Correspondingly, previous studies have frequently 
identified M. abscessus in smokers6,29,38. It therefore seems likely 
that tobacco smoke contributes to M. abscessus mutational burden, 
although overall substitution rates may be similar across different 
patient groups due to the action of other mutagens, such as high 
ROS levels in CF individuals35.
Our data therefore support a model where individuals with CF 
are the most permissive host for M. abscessus infection (as rapid 
expansion only occurred when this niche became available) but 
where smokers and other individuals without CF can act as an inef-
ficient reservoir for infection and long-distance transmission. This 
supports recent evidence that emerging M. abscessus lineages are 
evolving to become human adapted42. Strong evidence of M. absces-
sus transmission from individuals with CF2,8 and higher rates of 
infection in this group compared with other susceptible groups20 
support the importance of individuals with CF as key hosts for M. 
abscessus. Involvement of individuals without CF in transmission 
chains (Fig. 4) efficiently explains two previously puzzling observa-
tions; the missing epidemiological links between individuals with 
CF infected with highly genetically similar isolates identified in 
previous studies15–17, and the evidence for international transmis-
sion when individuals with CF have historically had limited inter-
continental travel. Furthermore, while infections do occur within 
hospitals8,9, our data indicate that many transmission events occur 
in other settings. Future studies incorporating a greater number of 
isolates from individuals without CF will be needed to determine 
the relative transmission rates between the different groups.
The population expansion that we describe in the DCCs only 
represents the initial expansion of these clones and epidemiological 
data indicate that the DCCs have continued to increase in preva-
lence to the present day1. While additional mechanisms have prob-
ably contributed, our data indicate that increasing person-to-person 
transmission is the key driver of the increased prevalence of M. 
abscessus. Our previous work2 demonstrated phenotypic differ-
ences between clustered and unclustered M. abscessus isolates and 
comparison with the analysis here showed that that work included 
isolates from DCCs 1, 2, 3 and also from the newly identified 4 and 
6 (but not DCCs 5 or 7). This shows that phenotypes associated 
with the clustered isolates are not limited to DCCs 1–3. However, 
further phenotyping comparing DCCs will be useful in future work. 
The seven DCCs are currently the only clones within the species 
whose expansion has been detected in our dataset. The more recent 
expansion of DCC4 (Fig. 1d) potentially occurred when this clone 
entered the population or had the opportunity to establish onward 
transmission. This coupled with the evidence for linkage between 
individuals carrying non-DCC strains (Fig. 4b), suggests that, as a 
species, M. abscessus is capable of human infection and transmis-
sion and that additional clones will continue to expand in the future 
when they have the opportunity to do so. Phylogeographic recon-
struction (Fig. 2a) did not identify the regions within which early 
circulation occurred and it is therefore difficult to forecast where 
additional clones may expand in the future. However, our data indi-
cate that it is reasonable to expect the early stages of expansion to 
occur within CF populations. Continued sequencing of clinical iso-
lates and comparison with global sequences will be important to 
detect any additional clones that emerge in the future.
Fig. 3 | DCCs exhibit a smoking-related mutational spectrum. a, Branch classification for each branch type. The left-hand tree illustrates the 
categorization of non-DCC branches into: within patient, which occur downstream of a node in the tree where all of the descendent sequences are from 
the same patient; tip branches and branches leading to within-patient clade ancestors where some of the evolution may have occurred within a patient; 
and internal branches where all the change is likely to have occurred in the environment. The right-hand tree illustrates the additional categorization of 
DCC branches into deep branches that precede the first population expansion. Note that in DCCs, all branch categories are likely to be within patients, not 
the environment. b, Inferred environmental mutational spectrum of M. abscessus as calculated from the internal branches of the non-DCCs. The mutational 
spectrum consists of six different mutations, shown in different colours, each in 16 different nucleotide contexts25. The bars show the proportion of the 
total mutations of that type in that context along the non-DCC internal branches. c, Mutational spectra attributable to mutations occurring (top) within 
patients with CF (on the basis of longitudinal isolates collected from infected individuals), and (bottom) during expansion and dissemination of the 
DCCs (on the basis of analysis of the internal phylogenetic branches of the DCCs excluding the deep branches, that is, after the population expansion). 
Results are shown as the difference from the environmental spectrum. Asterisks indicate significantly different proportions relative to the environmental 
mutational spectrum, calculated through permutation analysis. d, Deconvolution analysis reveals relative contributions of specific mutational processes to 
each spectrum: unassigned (grey), spontaneous (yellow), alkylating agent–associated (purple), ROS-associated (red) and smoking-related (blue).
NATuRe MICRoBIology | VOL 6 | OCTOBER 2021 | 1279–1288 | www.nature.com/naturemicrobiology 1283
Articles NAturE MiCrobiology
Further studies to understand how individuals without CF 
might transmit M. abscessus (both to individuals with and with-
out CF) are vital and may provide information on how to reduce 
transmission risk. However, from previous studies2,8,9 it is reason-
able to expect transmission to be indirect through the environ-
ment, and the role of individuals without CF in contaminating 
such environments requires particular attention. Comprehensive 
surveillance of potential environmental intermediates and isolates 
from individuals with and without CF may better define these 
transmission pathways.
In conclusion, reconstruction of the evolutionary history of 
the M. abscessus DCCs supports early emergence into non-CF 
populations, including smokers, followed by expansion due to 
person-to-person transmission that began with the emergence 
of the CF lung niche and has continued with contributions from 
individuals with and without CF. It also suggests that long-distance 
transmission may be due to low-level infection of individuals with-
out CF. Our study demonstrates the use of combining whole genome 
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Methods
Dataset construction, cluster identification and definition of DCCs. Whole 
genome sequencing of two collections of isolates from Manchester, UK, and the 
Netherlands was carried out as previously described2. Briefly, DNA was extracted 
from colony sweeps of subcultured samples before to paired-end sequencing 




















































































































Fig. 4 | Transmission network analyses. a, Number of isolates in each DCC from patients with CF and without (non-CF). b, Number and proportion of 
patients infected with DCCs and non-DCC strains showing genetic links at various SNP cut-offs (y axis). c, Number and proportion of linkages of different 
geographical distances at various SNP cut-offs, and those that are between and within patients with and without CF. d, Network diagrams at 10 and 38 
SNP cut-offs showing transmission clusters coloured by patients with and without CF. e, Detail of the largest cluster in the 38-SNP network showing 
the geographical location of patients and the network diagram coloured by geographical location. Nodes with black and grey outlines indicate city- and 
country-level information about isolate location, respectively.
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genome sequencing samples from previous studies2,10,12–16,18,43–46 to give a final 
dataset containing 2,045 samples from 1,178 patients. Samples were genotyped to 
the subspecies level using Mash47, comparing against one reference genome from 
each subspecies. Sample were assigned to the subspecies with the smallest genetic 
distance; all samples exhibited a clear subspecies assignment. A summary of all 
samples used, including sample accession numbers, is provided in Supplementary 
Table 3.
Sequencing reads from each sample were mapped against the corresponding 
subspecies reference sequence using the multiple_mappings_to_bam pipeline 
(https://github.com/sanger-pathogens/bact-gen-scripts) with BWA-MEM as  
the aligner. ATCC19977 (accession no. CU458896.1) was used as the reference  
for M. a. abscessus and CIP_108297 (accession no. GCF_001792625.1) for  
M. a. massiliense. SNPs were called from this alignment using the multiple_
mappings_to_bam pipeline. Subspecies phylogenetic trees were reconstructed 
using RAxML v.8.2.12 (ref. 48) with the general time reversible (GTR) model of 
nucleotide substitution and gamma rate heterogeneity with four gamma classes.  
To enable extraction of maximal genetic variation, clusters of samples were identified 
in the subspecies trees using FastBAPS49. This clustering identified 19 clusters in  
M. a. abscessus and 17 clusters in M. a. massiliense (Extended Data Fig. 1). A 
summary of each FastBAPS cluster is provided in Supplementary Table 1.
All subsequent analyses were carried out on each FastBAPS cluster 
independently. De novo assembly was carried out on each sample as previously 
described50 and the best assembly was identified for each FastBAPS cluster on the 
basis of number of contigs and N50-N90 values (Supplementary Table 1). Samples 
from each FastBAPS cluster were mapped against their respective best assembly as 
above to maximize the captured SNP diversity. Recombination was removed from 
FastBAPS cluster alignments using Gubbins v.2.4.1 (ref. 51) and phylogenetic trees 
were reconstructed for each FastBAPS cluster as above. Phylogenetic trees were 
viewed and figures constructed using FigTree52 and GGTREE53.
DCCs were identified as clusters of highly related sequences collected 
from at least 20 patients on multiple continents. DCCs 1, 2, 3, 5 and 7 are 
FastBAPS clusters while DCCs 4 and 6 are subclusters within a FastBAPS cluster 
(Supplementary Table 1). No DCCs were identified in M. a. bolletii.
Phylogenetic analyses, temporal, spatiotemporal and population 
reconstruction. Temporal phylogenetic reconstruction was carried out on DCCs 
1–7. DCC-specific datasets were constructed containing the earliest sequenced 
sample from each patient that clusters within the DCC. These samples were 
mapped against the respective DCC reference sequence (Supplementary Table 1) as 
above and a maximum likelihood phylogenetic tree reconstructed with RAxML48 
as above. Methods to infer substitution rates and ancestral dates are only valid if 
there is a temporal signal within the dataset54. We initially assessed temporal signal 
within each dataset using root-to-tip randomization. In each case, the maximum 
likelihood tree was rooted to minimize the heuristic residual mean square score 
using TempEst54. We examined the root-to-tip correlation visually (Extended Data 
Fig. 7a) and through comparison of the R2 correlation between sample collection 
date and root-to-tip distance with 1,000 randomizations of the tip dates to identify 
significance of the correlation. A significant positive correlation was observed for 
DCCs 1–4 (P < 0.001). We therefore initially reconstructed the temporal history 
of these DCCs using BEAST v.2.4.2 (ref. 19). We used the Hasegawa–Kishono–
Yano (HKY) model of nucleotide substitution. We used the relaxed log-normal 
clock model with a log-normal prior on the substitution rate with mean set to 
the estimated slope in TempEst and standard deviation 0.5. We modelled the 
population history using the coalescent Bayesian skyline population prior. At least 
three independent runs were carried out for 100,000,000 steps for each dataset. 
Convergence was assessed using Tracer v.1.7 (ref. 55).
As a more thorough test of temporal signal within each DCC, we carried 
out the date randomization test56. BEAST v.2.4.2 was run on each DCC dataset 
using a uniform substitution rate prior between 1 × 10−9 and 1 × 10−5, with these 
bounds chosen to encompass the likely substitution rates for Mycobacteria based 
on previous work2,56. Other priors were as described above. The results from these 
uniform prior runs were highly similar to those with the informed substitution 
rate prior in each case (Extended Data Fig. 8). Ten date randomizations were 
performed where the sequence collection dates were randomly assigned to tips. 
BEAST was run on each of these randomized datasets independently using the 
same uniform substitution rate prior (1 × 10−9 – 1 × 10−5). All four DCCs passed 
the date randomization test, defined here as the median posterior substitution 
rate and most recent common ancestor dates with the real sample collection dates 
not overlapping with that of any of the ten date randomizations (Extended Data 
Fig. 8). We did not attempt these analyses with DCCs 5–7 as they did not pass the 
correlation test.
The inferred substitution rates of DCCs 1–3 were highly similar (Extended 
Data Fig. 7b). The substitution rate of DCC4 is higher (Extended Data Fig. 
7b), probably due to this clade having a far more recent common ancestor date 
than DCCs 1–3 (Fig. 1c) and therefore less opportunity to remove deleterious 
substitutions. As DCCs 5–7 contain similar levels of diversity to DCCs 1–3 
(Extended Data Fig. 7c), we reconstructed their temporal history as above but 
using a uniform substitution rate prior with boundaries of 8.76 × 10−8 – 2.41 × 10−7, 
chosen as the upper and lower 95% highest probability density (HPD) substitution 
rate estimates for DCCs 1–3 (Extended Data Fig. 7b).
We determined whether each DCC has undergone a historical population 
expansion by using the Bayesian skyline plot estimates (Extended Data Fig. 9) of 
relative genetic diversity in the posterior distribution. We used all samples in the 
posterior distribution and found that all samples in all DCCs exhibited an increase 
in relative genetic diversity of more than tenfold relative to the value at the root 
of the tree, thereby strongly supporting a historical population expansion in each 
case. We identified the date of the expansion in each DCC by calculating the 
earliest date at which the relative genetic diversity increased by more than tenfold 
relative to the root of the tree and combined these values into a single distribution, 
from which the median and 95% HPD was calculated in each case.
Before carrying out spatiotemporal reconstruction, we calculated the 
association index57 of the distribution of collection continents across the maximum 
likelihood tree of each DCC. This was significant in each case on the basis of 
1,000 location randomizations (P < 0.001 in each DCC), indicating a correlation 
between phylogeny and continent of collection. We carried out asymmetric 
phylogeographic reconstructions of DCCs 1–3 using the BEAST_CLASSIC 
package v.1.3.2 in BEAST v.2.4.2 (ref. 19). Each sequence was labelled with the 
continent of collection. We used an informed log-normal substitution rate prior 
and Bayesian skyline population prior as above. We used an exponential prior on 
the overall rate of lineage movements with mean 1.0. The relative rates of migration 
between different continent pairs were modelled using a gamma distribution with 
alpha and beta both set to 1.0. As the number of sequences collected from each 
continent is unequal for each DCC, we assessed the robustness of our inferences 
by randomly subsampling the sequences from overrepresented continents and 
rerunning the spatiotemporal reconstruction. We carried out the subsampling five 
times and found that the results were highly similar in all subsamples (for example, 
Fig. 2b). Supported migration routes were identified using SPREAD v.0.9.6 (ref. 58)  
as directed continent pairs had Bayes factor support greater than three in the 
dataset without subsampling and at least four of the five subsampled datasets.
Mutational spectrum analysis. The mutational spectrum consists of all of 
the mutations that have occurred within the history of a sample set in their 
surrounding nucleotide context31. It is necessary to identify the direction of 
each mutation, that is, the parental nucleotide and the descendent nucleotide. 
To identify the mutations that have occurred and their direction, we carried 
out ancestral reconstruction on each FastBAPS cluster phylogenetic tree. 
Recombination was removed and phylogenetic trees reconstructed as above. 
Ancestral reconstruction was carried out on all variable alignment positions using 
the phylogenetic analysis by maximum likelihood (PAML) package v.4.9 (ref. 59). 
We compared the fit of HKY, HKY + GAMMA, GTR and GTR + GAMMA models 
of nucleotide substitution. Results were highly similar with all models and in all 
cases either the GTR or GTR + GAMMA model was supported. The mutations 
that occurred along each branch in the phylogeny were extracted from the PAML 
output. The surrounding nucleotide context of each mutation was identified from 
the reference sequence that was mapped against. The number of polymorphic sites 
contributing to each mutational spectrum is shown in Extended Data Fig. 10.
To compare the mutational spectrum in different niches, the branches in the 
phylogenetic tree were divided into categories (Fig. 3a). We reasoned that the 
internal branches within the non-DCC clusters will have been environmental as 
these branches probably often span hundreds to thousands of years during which 
time prolonged human infection will have been unlikely. We therefore calculated 
the environmental mutational spectrum by combining contextual mutations 
inferred along all internal branches of non-DCC clusters.
The phylogenetic branches within clades containing sequences from a 
single patient represent within-patient evolution. We therefore calculated the 
within-patient mutational spectrum by combining contextual mutations inferred 
along branches within monophyletic patient clades.
The relative contributions of environmental and within-patient evolution along 
tip branches and branches leading to patient ancestors is unclear as the patient 
may have acquired the infection at any point along this branch. We therefore 
did not include these branches in the environmental mutational spectrum or the 
within-patient spectrum.
To examine the mutations acquired during DCC transmission chains, we 
combined the contextual mutations that occurred along the internal branches 
within the seven DCC trees (Fig. 3a). We excluded the deep branches in these 
clades that precede population expansion (Fig. 3a) to only examine mutations that 
have occurred since emergence and therefore in more recent transmission chains.
We compared mutational spectra between niches by subtracting the 
inferred environmental spectrum from the DCC internal branch and within 
CF patient spectra. Significance of observed differences was assessed through 
1,000 independent down-samplings of the inferred environmental mutations 
to the number identified along DCC internal branches or within CF patients. 
Contextual mutations were identified as significant if their calculated proportion 
fell outside two standard deviations of the mean proportion in the 1,000 replicates. 
This process was repeated ten times and all reported significant mutations were 
significant in all ten runs.
Decomposition of the mutational spectrum into input signatures was carried 
out using signal32 (https://signal.mutationalsignatures.com/, date last accessed 15 
November 2020). The contextual mutations that were elevated in the DCCs relative 
to the environment were combined into a 10,000 mutation catalogue with their 
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relative frequencies representing their relative enrichment above the environment. 
This catalogue was used as input for signal specifying lung as the originating 
organ. Mutational drivers were assigned from the respective COSMIC mutational 
signature (https://cancer.sanger.ac.uk/cosmic/signatures/SBS/index.tt, date last 
accessed 15 November, 2020).
Transmission network reconstruction. SNP distances were calculated between all 
pairs of samples within each FastBAPS cluster using PairSNP60 and the minimum 
SNP distance between each pair of patients extracted. Patients were classified as 
being linked at a given SNP cut-off if their closest pair of samples differed by that 
number of SNPs or fewer. Localized linkages were classified on the basis of available 
metadata if the patients were in the sample hospital, CF Trust, city or state.
Transmission networks were reconstructed on the basis of minimum SNP 
distance between patient isolates. SNP distances of 20 and 38 SNPs were previously 
shown to represent ‘probable’ and ‘possible’ transmission, respectively, on the basis 
of the number of SNPs observed in within patient infections2. We therefore plotted 
the transmission network at ten SNPs to represent very likely transmission and 38 
SNPs to represent possible transmission.
Transmission network connectivity measures (Extended Data Fig. 6) were 
calculated using 38 SNPs as a cut-off to include linkages, with 38 chosen to 
include possible person-to-person transmission events2. Therefore, any patient 
linkages of 39 SNPs or more were not included. The total number of linkages 
involving patients with or without CF was identified and divided by the total 
number of patients within the respective group to calculate the average number 
of transmission linkages per patient with and without CF. To calculate the 
weighted connectivity measures, each edge in the transmission network was 
given a weighting of a 39-SNP distance. Therefore, edges linking patient pairs 
whose isolates differ by zero SNPs were given a weighting of 39 and edges had 
zero weighting if they connect patient pairs whose isolates differ by 39 or more 
SNPs. The total weighting of all edges involving patients with or without CF was 
identified and divided by the total number of patients within the respective group 
to calculate the average weighted connectivity. To identify the average weighting of 
CF–CF, CF–non-CF and non-CF–non-CF linkages, the total weighted connectivity 
of each edge type was calculated by summing the weights of all respective edges 
and this was divided by the total number of potential linkages of that type.
Trends in tobacco smoking. Annual estimates of the number of cigarette sales 
per adult per day were obtained from https://ourworldindata.org/smoking (last 
accessed 18 March 2021). 30 countries were included with data available from 
before 1960.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
All source data files are available at https://doi.org/10.5281/zenodo.5116229. 
Accession numbers of all samples used in analyses are included in this source data 
and in Supplementary Table 3. Source data are provided with this paper.
Code availability
Code used for data analysis is available at https://doi.org/10.5281/zenodo.5116229.
Received: 15 April 2021; Accepted: 18 August 2021;  
Published online: 20 September 2021
References
 1. Floto, R. A. et al. US Cystic Fibrosis Foundation and European Cystic 
Fibrosis Society consensus recommendations for the management of 
non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax 71, 
i1–i22 (2016).
 2. Bryant, J. M. et al. Emergence and spread of a human-transmissible 
multidrug-resistant nontuberculous mycobacterium. Science 354,  
751–757 (2016).
 3. Esther, C. R., Esserman, D. A., Gilligan, P., Kerr, A. & Noone, P. G. Chronic 
Mycobacterium abscessus infection and lung function decline in cystic fibrosis. 
J. Cyst. Fibros. 9, 117–123 (2010).
 4. Jarand, J. et al. Clinical and microbiologic outcomes in patients receiving 
treatment for Mycobacterium abscessus pulmonary disease. Clin. Infect. Dis. 
52, 565–571 (2011).
 5. Nessar, R., Cambau, E., Reyrat, J. M., Murray, A. & Gicquel, B. 
Mycobacterium abscessus: a new antibiotic nightmare. J. Antimicrob. 
Chemother. 67, 810–818 (2012).
 6. Kwak, N. et al. Mycobacterium abscessus pulmonary disease: individual 
patient data meta-analysis. Eur. Resp. J. https://doi.org/10.1183/ 
13993003.01991-2018 (2019).
 7. Taylor, J. L. & Palmer, S. M. Mycobacterium abscessus chest wall and 
pulmonary infection in a cystic fibrosis lung transplant recipient. J. Heart 
Lung Transplant. 25, 985–988 (2006).
 8. Bryant, J. M. et al. Whole-genome sequencing to identify transmission of 
Mycobacterium abscessus between patients with cystic fibrosis: a retrospective 
cohort study. Lancet 381, 1551–1560 (2013).
 9. Aitken, M. L. et al. Respiratory outbreak of Mycobacterium abscessus 
subspecies massiliense in a lung transplant and cystic fibrosis center.  
Am. J. Respir. Crit. Care Med. 185, 231–232 (2012).
 10. Davidson, R. M. et al. Genome sequencing of Mycobacterium abscessus 
isolates from patients in the United States and comparisons to globally 
diverse clinical strains. J. Clin. Microbiol. 52, 3573–3582 (2014).
 11. Davidson, R. M. A closer look at the genomic variation of geographically 
diverse Mycobacterium abscessus clones that cause human infection and 
disease. Front. Microbiol. https://doi.org/10.3389/fmicb.2018.02988 (2018).
 12. Tettelin, H. et al. High-level relatedness among Mycobacterium abscessus 
subsp. massiliense strains from widely separated outbreaks. Emerg. Infect. Dis. 
https://doi.org/10.3201/eid2003.131106 (2014).
 13. Yan, J. et al. Investigating transmission of Mycobacterium abscessus amongst 
children in an Australian cystic fibrosis centre. J. Cystic Fibros. https://doi.
org/10.1016/j.jcf.2019.02.011 (2019).
 14. Redondo, N. et al. Genomic analysis of an Irish population of Mycobacterium 
abscessus complex collected between 2006 and 2017. J. Clin. Microbiol. https://
doi.org/10.1128/JCM.00295-20 (2020).
 15. Doyle, R. M. et al. Cross-transmission is not the source of new 
Mycobacterium abscessus infections in a multi-centre cohort of cystic fibrosis 
patients. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciz526 (2019).
 16. Tortoli, E. et al. Mycobacterium abscessus in patients with cystic fibrosis: low 
impact of inter-human transmission in Italy. Eu. Resp. J. 50, 1602525 (2017).
 17. Harris, K. A. et al. Whole-genome sequencing and epidemiological analysis 
do not provide evidence for cross-transmission of Mycobacterium abscessus in 
a cohort of pediatric cystic fibrosis patients. Clin. Infect. Dis. 60,  
1007–1016 (2015).
 18. Hasan, N. A. et al. Population genomics of nontuberculous mycobacteria 
recovered from United States cystic fibrosis patients. Preprint at bioRxiv 
https://doi.org/10.1101/663559 (2019).
 19. Bouckaert, R. et al. BEAST 2: a software platform for Bayesian evolutionary 
analysis. PLoS Comput. Biol. 10, e1003537 (2014).
 20. Lee, M.-R. et al. Mycobacterium abscessus complex infections in humans. 
Emerg. Infect. Dis. https://doi.org/10.3201/eid2109.141634 (2015).
 21. Davis, P. B. Cystic fibrosis since 1938. Am. J. Respir. Crit. Care Med. 173, 
475–482 (2006).
 22. Dodge, J. A., Lewis, P. A., Stanton, M. & Wilsher, J. Cystic fibrosis mortality 
and survival in the UK: 1947–2003. Eur. Resp. J. 29, 522–526 (2007).
 23. Saiman, L. et al. Infection prevention and control guideline for cystic fibrosis: 
2013 update. Infect. Control Hospital Epidemiol. 35, s1–s67 (2014).
 24. Scotet, V., L’Hostis, C. & Férec, C. The changing epidemiology of cystic 
fibrosis: incidence, survival and impact of the CFTR gene discovery. Genes 
11, 589 (2020).
 25. Burgel, P.-R. et al. Future trends in cystic fibrosis demography in 34 European 
countries. Eur. Resp. J. 46, 133–141 (2015).
 26. Lake, M. A., Ambrose, L. R., Lipman, M. C. I. & Lowe, D. M. ‘Why me, why 
now?’ Using clinical immunology and epidemiology to explain who gets 
nontuberculous mycobacterial infection. BMC Med. 14, 54 (2016).
 27. Adjemian, J., Olivier, K. N., Seitz, A. E., Holland, S. M. & Prevots, D. R. 
Prevalence of nontuberculous mycobacterial lung disease in U.S. medicare 
beneficiaries. Am. J. Respir. Crit. Care Med. 185, 881–886 (2012).
 28. Bagaitkar, J., Demuth, D. R. & Scott, D. A. Tobacco use increases 
susceptibility to bacterial infection. Tob. Induc. Dis. https://doi.org/10.1186/ 
1617-9625-4-12 (2008).
 29. Lee, M.-R. et al. Risk factors for Mycobacterium chelonae-abscessus pulmonary 
disease persistence and deterioration. J. Infect. 64, 228–230 (2012).
 30. Kucab, J. E. et al. A compendium of mutational signatures of environmental 
agents. Cell 177, 821–836.e16 (2019).
 31. Nik-Zainal, S. et al. The genome as a record of environmental exposure. 
Mutagenesis 30, 763–770 (2015).
 32. Degasperi, A. et al. A practical framework and online tool for mutational 
signature analyses show intertissue variation and driver dependencies.  
Nat. Cancer 1, 249–263 (2020).
 33. Sedgwick, B. & Vaughan, P. Widespread adaptive response against 
environmental methylating agents in microorganisms. Mutat. Res. 250, 
211–221 (1991).
 34. Agarwal, M. K. Streptozotocin: mechanisms of action. FEBS Lett. 120,  
1–3 (1980).
 35. Brunel, S. F., Willment, J. A., Brown, G. D., Devereux, G. & Warris, A. 
Aspergillus-induced superoxide production by cystic fibrosis phagocytes is 
associated with disease severity. ERJ Open Res. 4, (2018).
 36. Alexandrov, L. B. et al. Mutational signatures associated with tobacco 
smoking in human cancer. Science 354, 618–622 (2016).
 37. Davies, B. S., Roberts, C. H., Kaul, S., Klein, J. L. & Milburn, H. J. 
Non-tuberculous slow-growing mycobacterial pulmonary infections in 
non-HIV-infected patients in south London. Scand. J. Infect. Dis. 44,  
815–819 (2012).
NATuRe MICRoBIology | VOL 6 | OCTOBER 2021 | 1279–1288 | www.nature.com/naturemicrobiology 1287
Articles NAturE MiCrobiology
 38. Koh, W.-J. et al. Clinical significance of differentiation of Mycobacterium 
massiliense from Mycobacterium abscessus. Am. J. Respir. Crit. Care Med. 183, 
405–410 (2011).
 39. O’Leary, S. M. et al. Cigarette smoking impairs human pulmonary immunity 
to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 190, 1430–1436 
(2014).
 40. Feng, Y. et al. Exposure to cigarette smoke inhibits the pulmonary T-cell 
response to influenza virus and Mycobacterium tuberculosis. Infect. Immun. 
79, 229–237 (2011).
 41. Arcavi, L. & Benowitz, N. L. Cigarette smoking and infection. Arch. Intern. 
Med. 164, 2206–2216 (2004).
 42. Bryant, J. M. Stepwise pathogenic evolution of Mycobacterium abscessus. 
Science 372, eabb8699 (2021).
 43. Li, B. et al. Relationship between antibiotic susceptibility and genotype in 
Mycobacterium abscessus clinical isolates. Front. Microbiol. https://doi.
org/10.3389/fmicb.2017.01739 (2017).
 44. Davidson, R. M. et al. Phylogenomics of Brazilian epidemic isolates of 
Mycobacterium abscessus subsp. bolletii reveals relationships of global 
outbreak strains. Infect., Genet. Evolution 20, 292–297 (2013).
 45. Sapriel, G. et al. Genome-wide mosaicism within Mycobacterium abscessus: 
evolutionary and epidemiological implications. BMC Genomics 17,  
118 (2016).
 46. Ripoll, F. et al. Non mycobacterial virulence genes in the genome of the 
emerging pathogen Mycobacterium abscessus. PLoS ONE 4, e5660 (2009).
 47. Ondov, B. D. et al. Mash: fast genome and metagenome distance estimation 
using MinHash. Genome Biol. 17, 132 (2016).
 48. Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and 
post-analysis of large phylogenies. Bioinformatics 30, 1312–1313 (2014).
 49. Tonkin-Hill, G., Lees, J. A., Bentley, S. D., Frost, S. D. W. & Corander, J. Fast 
hierarchical Bayesian analysis of population structure. Nucleic Acids Res. 47, 
5539–5549 (2019).
 50. Page, A. J. et al. Robust high-throughput prokaryote de novo assembly and 
improvement pipeline for Illumina data. Microb. Genomics 2, e000083 (2016).
 51. Croucher, N. J. et al. Rapid phylogenetic analysis of large samples of 
recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids 
Res. 43, e15 (2015).
 52. Rambaut, A. FigTree. http://tree.bio.ed.ac.uk/software/figtree/ (GitHub, 2007).
 53. Yu, G., Smith, D. K., Zhu, H., Guan, Y. & Lam, T. T.-Y. ggtree: an R package 
for visualization and annotation of phylogenetic trees with their covariates 
and other associated data. Meth. Ecol. Evol. 8, 28–36 (2017).
 54. Rambaut, A., Lam, T. T., Max Carvalho, L. & Pybus, O. G. Exploring the 
temporal structure of heterochronous sequences using TempEst (formerly 
Path-O-Gen). Virus Evol. 2, vew007 (2016).
 55. Rambaut, A., Drummond, A. J., Xie, D., Baele, G. & Suchard, M. A. Posterior 
summarization in Bayesian phylogenetics using tracer 1.7. Syst. Biol. 67, 
901–904 (2018).
 56. Menardo, F., Duchêne, S., Brites, D. & Gagneux, S. The molecular clock of 
Mycobacterium tuberculosis. PLoS Pathog. 15, e1008067 (2019).
 57. Parker, J., Rambaut, A. & Pybus, O. G. Correlating viral phenotypes with 
phylogeny: accounting for phylogenetic uncertainty. Infect. Genet. Evol. 8, 
239–246 (2007).
 58. Bielejec, F., Rambaut, A., Suchard, M. A. & Lemey, P. SPREAD: spatial 
phylogenetic reconstruction of evolutionary dynamics. Bioinformatics 27, 
2910–2912 (2011).
 59. Yang, Z. PAML 4: phylogenetic analysis by maximum likelihood. Mol. Biol. 
Evol. 24, 1586–1591 (2007).
 60. Tonkin-Hill, G. pairsnp. https://github.com/gtonkinhill/pairsnp (GitHub, 
2020).
Acknowledgements
Funding for this work was provided by The Wellcome Trust (investigator award no. 
107032/Z/15/Z to R.A.F.), Fondation Botnar (Programme grant no. 6063) and the UK CF 
Trust (Innovation Hub award no. 001; Strategic Research Centre award no. 010). M.S., 
N.A.H. and R.M.D. acknowledge the Cystic Fibrosis Foundation for funding.
Author contributions
C.R. worked on study conception and design, dataset construction and analyses, 
manuscript writing and manuscript editing. J.M.B. worked on study design, dataset 
analyses and manuscript editing. S.B. worked on dataset construction and manuscript 
editing. R.T. worked on dataset construction and manuscript editing. R.M.D. worked on 
dataset construction and manuscript editing. N.A.H. worked on dataset construction 
and manuscript editing. J.v.I. worked on dataset construction and manuscript editing. 
R.A.F. worked on study conception and design, funding acquisition and supervision, 
manuscript writing and manuscript editing. J.P. worked on study conception and design, 
funding acquisition, supervision, manuscript writing and manuscript editing. All authors 
have read and approved the final paper.
Competing interests
The authors declare no competing interests.
Additional information
Extended data is available for this paper at https://doi.org/10.1038/s41564-021-00963-3.
Supplementary information The online version contains supplementary material 
available at https://doi.org/10.1038/s41564-021-00963-3.
Correspondence and requests for materials should be addressed to 
R. Andres Floto or Julian Parkhill.
Peer review information Nature Microbiology thanks Daniel Falush, Sebastien Gagneux 
and the other, anonymous, reviewers for their contribution to the peer review of this 
work
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in 
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons 
Attribution 4.0 International License, which permits use, sharing, adap-
tation, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, provide a link to 
the Creative Commons license, and indicate if changes were made. The images or other 
third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons license and your intended use is not permitted by statu-
tory regulation or exceeds the permitted use, you will need to obtain permission directly 
from the copyright holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/.
© The Author(s) 2021
NATuRe MICRoBIology | VOL 6 | OCTOBER 2021 | 1279–1288 | www.nature.com/naturemicrobiology1288
ArticlesNAturE MiCrobiology
Extended Data Fig. 1 | Population structure of M. abscessus. A phylogenetic tree was reconstructed containing all isolates from all individuals (n = 1335 for 
M. abscessus subsp abscessus (M. a. abscessus), n = 710 for M. a. massiliense). As Fig. 1a but no clades were collapsed in this tree. The sequences that cluster 
within each DCC are labelled. FastBAPS clusters are plotted next to the tree for M. a. abscessus (green) which contains 19 FastBAPS clusters and M. a. 
massiliense (black) which contains 17 FastBAPS clusters.
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Extended Data Fig. 2 | Drivers of the concurrent DCC expansion. The bottom panel shows the expansion date distribution for each of the DCCs, as 
in Fig. 1d (number of samples from the posterior distribution: DCC1 = 2255, DCC2 = 2255, DCC3 = 2255, DCC4 = 2699, DCC5 = 2702, DCC6 = 2613, 
DCC7 = 2703). Boxplot centre lines show median value, upper and lower bounds show the 25th and 75th quantile, respectively, upper and lower whiskers 
show the largest and smallest values within 1.5 times the interquartile range above the 75th percentile and below the 25th percentile, respectively, and 
points show samples outside of the whisker range. The top panel shows factors within the CF population that likely drove DCC expansion. The middle 
panel shows the trend in cigarette sales in developed countries; each blue line is the trend in a single country and the black line is the average trend across 
countries combined.
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Extended Data Fig. 3 | older phylogenetic clades contain sequences from more continents than more recent phylogenetic clades. The age and number 
of continents descendent sequences were sampled from was calculated for all clades across the posterior distribution of phylogenetic trees (number of 
clades: DCC1 = 539847, DCC2 = 173635, DCC3 = 182655). Boxplots depict all clades from all trees. The distribution of clades ages is significantly different 
for all pairs of continent numbers for all DCCs (Bonferroni corrected two sample two-sided Kolmogorov-Smirnov test, p < 0.001).
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Extended Data Fig. 4 | CF and non-CF patient isolates are intermingled in DCC phylogenetic trees and infected with non-DCCs. (a) Maximum likelihood 
phylogenetic trees are shown for each DCC with tips coloured by CF status. The scale bars show expected nucleotide substitutions per variable genome 
site. (b) All non-DCC isolates from each subspecies are combined.
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Extended Data Fig. 5 | Transmission summaries divided into M. a. abscessus and M. a. massiliense. Pairs of individuals are classified as linked at a given 
SNP cut-off if their closest related isolates differ by fewer than that number of SNPs. (a) Linkages at each SNP cut-off split by subspecies. (b) Linkages 
were classified as local if the individuals are from the same hospital, CF center, city or state. Within country linkages are pairs of individual within the same 
country that do not meet the criteria for local. (c) Linkages were classified based on the CF status of the two individuals.
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Extended Data Fig. 6 | CF and non-CF individuals are well connected within the transmission network. Network connectivity scores were calculated 
from the transmission calculated at a cutoff of 38 SNPs presented in Fig. 4D. (a) The number of connections exhibited by each individual in the network 
was calculated and split into CF and non-CF individuals. The mean number of connections exhibited by an individual with the corresponding CF status 
is plotted. (b) Each connection in the transmission network was given a weighting based on the minimum SNP distance between isolates from the 
corresponding individuals, calculated as ‘39 – minimum SNP distance’. Therefore linkages representing fewer SNPs are given a higher weighting, the 
maximum weighting is 38 if isolates from two individuals differ by 0 SNPs and linkages at 38 SNPs have a weighting of 1. The weighted linkages of all 
individuals with the corresponding CF status were summed and divided by the number of individuals with that status. (c) Connections in the transmission 
network were divided into three categories based on the CF status of the two linked individuals: CF < - >CF, CF < - >non-CF, non-CF < - >non-CF. Linkages 
were weighted as in (b). All weighted linkages within each type of linkage were summed and divided by the total number of potential linkages between 
individuals with the corresponding CF status.
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Extended Data Fig. 7 | Assessment of DCC root-to-tip correlation and substitution rate comparison. (a) DCC root-to-tip distance vs collection date. 
Dashed lines represent the regression line between root-to-tip distance and collection date. Correlations were calculated from maximum likelihood 
phylogenetic trees. DCCs 1-4 exhibited a significant correlation based on bootstrap analyses while DCCs 5-7 did not. (b) Comparison of DCC 1-4 
substitution rates. Substitution rate estimates are plotted for each DCC based on the posterior distribution (number of samples from the posterior 
distribution: DCC1 = 2255, DCC2 = 2255, DCC3 = 2255, DCC4 = 2703). Points represent median estimates and bars the 95% HPD. The substitution rate 
is highly similar for DCCs 1-3. (c) Comparison of divergence levels in each DCC. Phylogenetic trees were reconstructed for each DCC and midpoint rooted. 
Plotted is the root-to-tip distance (substitutions/genome site from the root of the tree each tip) for each sequence in each DCC (number of sequences: 
DCC1 = 172, DCC2 = 78, DCC3 = 82, DCC4 = 16, DCC5 = 15, DCC6 = 19, DCC7 = 22). DCC4 has accumulated substantially less divergence than the other 
DCCs.
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Extended Data Fig. 8 | DCCs 1-4 exhibit a significant temporal signal. Date randomization test for DCCs 1-4. Points show median values and error bars 
the 95% HPD (number of samples from the posterior distribution: DCC1 informed, DCC1 uniform, DCC2 informed, DCC3 informed, DCC3 uniform = 2255 
each, DCC4 informed, DCC4 uniform, all date randomisations = 2703 each, DCC2 uniform = 4506). The temporal evolutionary history of each DCC was 
reconstructed with an informed prior on the substitution rate based on root-to-tip analysis and a uniform prior (see methods). The results from these 
priors matched closely in all cases. We compared the tree root date and substitution rate inferences from these priors with ten date randomization runs 
where the sample collection dates were randomly assigned to sequences and the temporal history reconstructed. In all cases, the posterior distributions 
inferred with the real dates were highly different from those inferred with the date randomizations, suggesting the existence of a significant temporal signal 
within each DCC.
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Extended Data Fig. 9 | DCC Bayesian skyline plots. The relative genetic diversity (Neτ) is shown through time for each DCC as estimated from BEAST 
analyses. The black line represents the median estimate and the shaded area the 95% HPD.
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Extended Data Fig. 10 | Polymorphic sites used in the mutational spectra analyses. The number of alignment sites within each FastBAPS cluster used 
for mutational spectrum analysis of the environmental, within-CF patient and DCC internal branches is shown. Some of these sites will have mutated on 
multiple occasions within a FastBAPS cluster so the number of polymorphic sites is not the same as the number of mutations. M.a: M. abscessus subsp 
abscessus. M.m: M. abscessus subsp massiliense.
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Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency 
in reporting. For further information on Nature Research policies, see our Editorial Policies and the Editorial Policy Checklist.
Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) 
AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection No software was used in collection of the data
Data analysis Phylodynamic and phylogeographic analyses were performed with BEAST v2.4.2. Convergence of log files was examined with Tracer v1.7. 
Examination of temporal signal was carried out with TempEst v1.5.1. Read mapping was performed using the multiple_mappings_to_bam 
pipeline v1.6. Cluster assignment was carried out using FastBAPS v1.0.0. Initial assignment of samples to subspecies was carried out using 
mash v2.1.1. Recombination was removed using gubbins v2.4.1. Reconstruction of non-temporal trees was carried out with RAxML v8.2.12. 
Trees were viewed with FigTree v1.4.4 and GGTREE v3. Supported inter-continental movements were identified with SPREAD v0.9.6. 
Nucleotide substitutions were reconstructed onto phylogenetic trees using PAML v4.9. SNP distances between sequence pairs were 
calculated using PairSNP v0.0.1. Additional custom scripts, including those used to calculate mutational spectra are available in GitHub at DOI 
https://doi.org/10.5281/zenodo.4279139.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors and 
reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
The accession codes for all sequences used in this study are provided in Table S3. All source data, including alignments, phylogenetic trees, BEAST XML files and 
mutational spectra have been deposited in https://doi.org/10.5281/zenodo.5116229.
Field-specific reporting
Please select the one below that is the best fit for your research. If you are not sure, read the appropriate sections before making your selection.
Life sciences Behavioural & social sciences  Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf
Ecological, evolutionary & environmental sciences study design
All studies must disclose on these points even when the disclosure is negative.
Study description Phylogenetic clustering of available whole genome sequences followed by phylodynamic and phylogeographic analysis of selected 
clones. Mutational spectrum analysis comparing between clusters. Transmission network analysis of whole genome sequences.
Research sample Raw data was 2045 whole genome sequencing samples of Mycobacterium abscessus available on the European Nucleotide Archive. 
This data represents the global population structure of Mycobacterium abscessus
Sampling strategy We included all available whole genome sequencing samples which capture the diversity from over 1100 patients on five continents
Data collection Data was downloaded from the European Nucleotide Archive, sample metadata was obtained from authors of previous studies or 
data tables in previous studies
Timing and spatial scale We used all available while genome sequencing samples, which were collected between 1998 and 2017. These samples were 
collected from 16 countries on 5 continents. We retained all available samples to maximise sequence, temporal and spatial diversity
Data exclusions No data were excluded from the study
Reproducibility All Bayesian analyses involved at least three independent runs and results were highly similar between runs. Phylogeographic 
analyses were carried out with all data and with five independent down-samplings of over-represented locations. All repeats were 
successful and all repeat analyses showed the same results
Randomization Samples were divided into clusters based on phylogenetic relationships. Cluster cut-offs were assigned using hierarchical Bayesian 
analysis of population structure
Blinding All samples were coded by unique lab identification and therefore all associated metadata are anonymised
Did the study involve field work? Yes No
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
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Dual use research of concern
Methods
n/a Involved in the study
ChIP-seq
Flow cytometry
MRI-based neuroimaging
